17.31
price up icon0.64%   0.11
after-market After Hours: 17.31
loading
Adma Biologics Inc stock is traded at $17.31, with a volume of 1.82M. It is up +0.64% in the last 24 hours and down -3.03% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$17.20
Open:
$17.23
24h Volume:
1.82M
Relative Volume:
0.56
Market Cap:
$4.13B
Revenue:
$426.45M
Net Income/Loss:
$197.67M
P/E Ratio:
21.11
EPS:
0.82
Net Cash Flow:
$110.10M
1W Performance:
-1.59%
1M Performance:
-3.03%
6M Performance:
+7.65%
1Y Performance:
+27.47%
1-Day Range:
Value
$16.97
$17.36
1-Week Range:
Value
$16.50
$17.69
52-Week Range:
Value
$10.21
$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Name
Adma Biologics Inc
Name
Phone
(201) 478-5552
Name
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Employee
685
Name
Twitter
@AdmaBiologics
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ADMA
Adma Biologics Inc
17.31 4.07B 426.45M 197.67M 110.10M 0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-19-23 Resumed Raymond James Strong Buy
Oct-13-22 Initiated Mizuho Buy
Nov-11-21 Upgrade Raymond James Outperform → Strong Buy
Nov-09-21 Initiated Cantor Fitzgerald Overweight
Jun-04-19 Initiated Jefferies Buy
Apr-15-19 Reiterated H.C. Wainwright Buy
Feb-07-19 Resumed H.C. Wainwright Buy
Dec-11-17 Reiterated Maxim Group Buy
Nov-14-17 Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17 Upgrade Maxim Group Hold → Buy
Aug-01-16 Downgrade Maxim Group Buy → Hold
Jul-25-16 Reiterated Maxim Group Buy
May-13-15 Reiterated Maxim Group Buy
Dec-08-14 Initiated Oppenheimer Outperform
Dec-01-14 Reiterated Maxim Group Buy
View All

Adma Biologics Inc Stock (ADMA) Latest News

pulisher
Jul 23, 2025

What analysts say about ADMA Biologics Inc. stockTremendous portfolio expansion - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is ADMA Biologics Inc. a good long term investmentFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Heavy Insider Selling at ADMA Biologics Despite Earnings Strength - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives ADMA Biologics Inc. stock priceExceptional growth trajectory - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

ADMA Biologics Inc. Stock Analysis and ForecastMassive portfolio appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 21, 2025

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

We Think ADMA Biologics (NASDAQ:ADMA) Can Manage Its Debt With Ease - 富途牛牛

Jul 20, 2025
pulisher
Jul 20, 2025

Institutional investors in ADMA Biologics, Inc. (NASDAQ:ADMA) lost 9.6% last week but have reaped the benefits of longer-term growth - simplywall.st

Jul 20, 2025
pulisher
Jul 20, 2025

Where are the Opportunities in (ADMA) - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

ADMA Biologics Plunges 4.89% Amid Insider Selling Concerns - AInvest

Jul 18, 2025
pulisher
Jul 17, 2025

ADMA Biologics Shares Plunge 5.84% Amid Insider Trading Concerns - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

How ADMA Biologics Inc. stock performs during market volatility3x Return Stock Radar - beatles.ru

Jul 17, 2025
pulisher
Jul 17, 2025

ADMA Biologics' Insider Transactions: A Strategic Exit or a Vote of Confidence? - AInvest

Jul 17, 2025
pulisher
Jul 15, 2025

Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors - Yahoo Finance

Jul 15, 2025
pulisher
Jul 14, 2025

ADMA Biologics, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Jul 14, 2025
pulisher
Jul 14, 2025

ADMA Biologics, Inc. Rings the Opening Bell - Nasdaq

Jul 14, 2025
pulisher
Jul 09, 2025

Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

(ADMA) Proactive Strategies - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 08, 2025

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance

Jul 08, 2025
pulisher
Jun 29, 2025

(ADMA) Investment Analysis - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 28, 2025

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jun 28, 2025
pulisher
Jun 27, 2025

Implied Volatility Surging for ADMA Biologics Stock Options - TradingView

Jun 27, 2025
pulisher
Jun 27, 2025

Will Strong Asceniv Sales Drive ADMA Biologics Further? - Zacks Investment Research

Jun 27, 2025
pulisher
Jun 25, 2025

ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

ADMA Biologics (ADMA) Drops 14.7% W/W as 3 Execs Unload Portfolios - Insider Monkey

Jun 24, 2025
pulisher
Jun 20, 2025

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - Nasdaq

Jun 20, 2025
pulisher
Jun 19, 2025

ADMA Biologics (ADMA) Drops for 5th Consecutive Day – Here’s Why - Insider Monkey

Jun 19, 2025
pulisher
Jun 18, 2025

(ADMA) On The My Stocks Page - news.stocktradersdaily.com

Jun 18, 2025

Adma Biologics Inc Stock (ADMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Cap:     |  Volume (24h):